Skip to main content
Clinical Trials/CTRI/2020/04/024929
CTRI/2020/04/024929
Not yet recruiting
未知

Comparison of the efficacy of Triple , Quadruple and Sequential Antibiotic Therapy in Eradicating Helicobacter pylori infection- A randomized controllled trial

AIIMS BHUBANESWAR0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
AIIMS BHUBANESWAR
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.H. Pylori positive cases of both gender who are between 18\-80 years of age and are willing to receive eradication therapy for H. pylori.
  • 2\.Willing to provide written informed consent

Exclusion Criteria

  • 1\.Previous eradication therapy for H. pylori
  • 2\.History of gastrectomy
  • 3\.Gastric malignancy, including adenocarcinoma and lymphoma
  • 4\.Previous allergic reaction to antibiotics (amoxicillin, clarithromycin,tinidazole) and prompt pump inhibitors (esmeprazole)
  • 5\.Use of antibotics (amoxicillin,clarithromycin,tinidazole) in recent 4 weeks.
  • 6\.Contraindication to treatment drugs
  • 7\.Pregnant or lactating women
  • 8\.Severe concurrent disease or malignancy

Outcomes

Primary Outcomes

Not specified

Similar Trials